The sole purpose of OculoStem, LLC is to hold and manage securities and bonds, to hold and manage patents, and to loan funds generated from its investment income to other companies for research and development. OculoStem concentrates on patents for the treatment of eye diseases such as Retinitis Pigmentosa, Macular Degeneration, and Glaucoma.